LONG BRANCH, N.J., May 2 /PRNewswire/ -- The organizers of Pharma ChemOutsourcing Conference & Exhibition have unveiled this year's extraordinary assembly of pharmaceutical and biotech company speakers who will gather in September. Interest has reached a new peak around the exploding chemical outsourcing activities reshaping R & D and commercial manufacturing activities of the industry, reports Apaporis LLC. The conference program may be accessed via this link: http://www.chemoutsourcing.com/2008_agenda.php
Pharmaceutical outsourcing managers from Merck, Pfizer, J & J, Wyeth,
and the gamut of large, mid-sized, and increasingly, biotech companies with
small molecule efforts comprise the majority of attendees. Comprehensive
coverage of challenges they face are discussed by industry peers in
audience-interactive fashion. Topics of special interest in 2008 include:
-- New Regulations in Asia
-- Biotech's Special Small Molecule Needs
-- API Sourcing
-- Raw Materials & Supply Chain
-- Phase II and Commercial Sourcing
-- Sourcing Synthetic Route Design & Process Optimization
-- Supplier Performance Metrics
-- Medicinal Chemistry Sourcing
-- Discovery Outsourcing
The conference is geared around a variety of concurrent sessions on the multi-tracked program and studded with receptions, dinners, and other socializing events facilitated by the beachfront resort location on the "JerseyShore". The intimate gathering of 500-750 facilitates learning and attendee information exchange.
The 2008 keynote is:
Is The Pharmaceutical Industry Exposing Itself to Unacceptable Risk by
Expanding Offshore Outsourcing?
Stefan Loren, Ph.D.
Perceptive Life Sciences
The finest suppliers from the USA, Europe, and increasingly, India will
be on hand to exhibit and network. The exhibit
|SOURCE Apaporis LLC|
Copyright©2008 PR Newswire.
All rights reserved